Two Sigma Investments
ROIV icon

Two Sigma Investments’s Roivant Sciences ROIV Stock Holding History

Two Sigma Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,100
Closed -$143K – 3450
2024
Q4 		$143K Sell
12,100
-111
-0.9% -$1.31K ﹤0.01% 2923
2024
Q3 		$141K Buy
12,211
+68
+0.6% +$774 ﹤0.01% 2852
2024
Q2 		$128K Sell
12,143
-29,200
-71% -$320K ﹤0.01% 2795
2024
Q1 		$436K Sell
41,343
-172,557
-81% -$1.86M ﹤0.01% 2397
2023
Q4 		$2.4M Sell
213,900
-340,564
-61% -$3.32M 0.01% 1393
2023
Q3 		$6.48M Sell
554,464
-496,772
-47% -$5.62M 0.02% 776
2023
Q2 		$10.6M Sell
1,051,236
-168,681
-14% -$1.51M 0.03% 622
2023
Q1 		$9M Buy
1,219,917
+1,194,317
+4,665% +$9.83M 0.03% 631
2022
Q4 		$205K Buy
+25,600
New +$142K ﹤0.01% 2382
2022
Q2 		– Sell
-50,158
Closed -$248K – 2874
2022
Q1 		$248K Buy
50,158
+29,794
+146% +$197K ﹤0.01% 2279
2021
Q4 		$205K Buy
+20,364
New +$169K ﹤0.01% 3921

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Two Sigma Investments's ROIV Position: Q1 2025 in Review

Two Sigma Investments sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 12,100 shares — an estimated $143K sold.

Two Sigma Investments first reported a position in ROIV in Q4 2021 and held it in 11 quarters. The position peaked at $10.6M in Q2 2023. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Two Sigma Investments reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 12,100 Roivant Sciences shares in Q1 2025, an estimated $143K.
  • Two Sigma Investments first reported a position in Roivant Sciences in Q4 2021 and held it in 11 quarters.
  • Two Sigma Investments's Roivant Sciences position peaked at $10.6M in Q2 2023.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.